Johnson Matthey (OTCMKTS:JMPLY) Downgraded to “Hold” Rating by Zacks Research

Zacks Research downgraded shares of Johnson Matthey (OTCMKTS:JMPLY) from a strong-buy rating to a hold rating in a research report released on Thursday,Zacks.com reports.

JMPLY has been the topic of a number of other research reports. Citigroup restated a “neutral” rating on shares of Johnson Matthey in a research note on Tuesday, October 21st. Jefferies Financial Group raised Johnson Matthey to a “strong-buy” rating in a report on Thursday, October 9th. One investment analyst has rated the stock with a Strong Buy rating and three have given a Hold rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy”.

Johnson Matthey Stock Up 0.6%

JMPLY stock traded up $0.34 during midday trading on Thursday, reaching $55.95. 1,868 shares of the company’s stock traded hands, compared to its average volume of 3,191. Johnson Matthey has a 52-week low of $29.01 and a 52-week high of $58.40. The stock’s 50-day moving average is $54.59 and its 200 day moving average is $48.56. The company has a quick ratio of 1.01, a current ratio of 1.42 and a debt-to-equity ratio of 0.57.

About Johnson Matthey

Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers’ products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet’s natural resources.